-Non-Muscle-Invasive Bladder Cancer (NMIBC) – Stage 0, I
• TURBT (Transurethral Resection of Bladder Tumor) – First-line endoscopic resection for superficial tumors.
• Intravesical Therapy (BCG / Chemotherapy) – Mitomycin C or Bacillus Calmette-Guérin (BCG) to prevent recurrence and progression.
• Close Surveillance (Cystoscopy & Urine Cytology) – Regular monitoring to detect early recurrence.
– Muscle-Invasive Bladder Cancer (MIBC) – Stage II, III
• Neoadjuvant Chemotherapy – Cisplatin-based chemotherapy to downstage tumors pre-surgery.
• Radical Cystectomy (Laparoscopic / Robotic-Assisted) – Complete bladder removal with urinary diversion (ileal conduit/neobladder reconstruction).
• Bladder Preservation Therapy (Radiation + Chemotherapy) – Combined modality treatment for select patients unfit for cystectomy.
– Advanced & Metastatic Bladder Cancer – Stage IV
• Systemic Chemotherapy (Platinum-Based Regimens) – First-line therapy for metastatic disease.
• Immunotherapy (Checkpoint Inhibitors – PD-1/PD-L1 inhibitors) – Targeted immunotherapy for chemo-refractory cases.
• Palliative Care & Symptom Management – Pain control, urinary diversion, and supportive care for quality-of-life improvement.
Dr. Soumyan Dey, practicing at leading Clinic in Navi Mumbai, Dr. Dey’s Urocare provides precision-driven, evidence-based bladder cancer treatment with a focus on organ preservation, minimal morbidity, and long-term survival.
